Abstract |
Peripheral vasculopathies cause severe wound hypoxia inducing the hypoxamiR miR-210. High level of miR-210, persisting in wound-edge tissue as ischemic memory, suppresses oxidative metabolism and inhibits cell proliferation necessary for healing. In wound-edge tissue of chronic wound patients, elevated miR-210 was tightly associated with inhibition of epidermal cell proliferation as evident by lowered Ki67 immunoreactivity. To inhibit miR-210 in murine ischemic wound-edge tissue, we report the formulation of antihypoxamiR functionalized gramicidin lipid nanoparticles (AFGLN). A single intradermal delivery of AFGLN encapsulating LNA-conjugated anti-hypoximiR-210 (AFGLNmiR-210) lowered miR-210 level in the ischemic wound-edge tissue. In repTOP™mitoIRE mice, AFGLNmiR-210 rescued keratinocyte proliferation as visualized by in vivo imaging system (IVIS). 31P NMR studies showed elevated ATP content at the ischemic wound-edge tissue following AFGLNmiR-210 treatment indicating recovering bioenergetics necessary for healing. Consistently, AFGLNmiR-210 improved ischemic wound closure. The nanoparticle based approach reported herein is effective for miR-directed wound therapeutics warranting further translational development.
|
Authors | Subhadip Ghatak, Jilong Li, Yuk C Chan, Surya C Gnyawali, Erin Steen, Bryant C Yung, Savita Khanna, Sashwati Roy, Robert J Lee, Chandan K Sen |
Journal | Nanomedicine : nanotechnology, biology, and medicine
(Nanomedicine)
Vol. 12
Issue 7
Pg. 1827-1831
(10 2016)
ISSN: 1549-9642 [Electronic] United States |
PMID | 27033464
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier Inc. All rights reserved. |
Chemical References |
- Anti-Bacterial Agents
- Lipids
- MicroRNAs
- Gramicidin
|
Topics |
- Animals
- Anti-Bacterial Agents
(administration & dosage)
- Gramicidin
(administration & dosage)
- Humans
- Ischemia
(metabolism)
- Keratinocytes
- Lipids
- Mice
- MicroRNAs
- Nanoparticles
- Wound Healing
|